Table 5.

Long-term oncologic outcomes of patients in randomized control trials

Ref.	Mean F/U (mo)		LR (%)		DFS (%)		OS (%)
	Open	Lap	Open	Lap	Open	Lap	Open	Lap
Kang et al[40]	NA	NA	NA	NA	NA	NA	NA	NA
Ng eet al[45]	108.8 (69.8-168.7)	112.5 (71.1-168.3)	7.1	4.9	80.4 (5.1)	82.9 (4.9)	55.1 (6.5)	63.9 (6.6)
Lujan et al[31]	34.1 (20)	32.8 (18.9)	5.3	4.8	81	84.8	75.3	42.1
Ng et al[39]	90.1 (27.0-145.5)	87.2 (22.8-150.0)	11.1	5	73.6 (8.1)	78.1 (6.9)	76.5 (7.3)	75.2 (7.2)
Guillou et al[7]/Jayne et al[12]	36.8 (20.0-61.5)	36.8 (20.0-61.5)	10.1	9.7	70.4/46.9	70.9/49.8	66.7/57.7	74.6/65.2
Braga et al[38]	53.6	53.6	5.2	4	NA	NA	NA	NA
Zhou et al[35]	1.0-16.0	1.0-16.0	NA	NA	NA	NA	NA	NA
Araujo et al[34]	47.2	47.2	13.3	0	NA	NA	NA	NA

F/U: Follow-up; LR: Local recurrence; DFS: Disease-free survival; OS: Overall survival; NA: Not available.